Pagibaximab
From Wikipedia, the free encyclopedia
Pagibaximab?
|
|
Therapeutic monoclonal antibody | |
Source | Chimeric |
Target | ? |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C6462H9996N1728O2028S54 |
Mol. mass | ? |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Pagibaximab is a chimeric monoclonal antibody and which it is used to treat bacterial infections.
|